Regular monitoring should include pancreatitis screening through amylase and lipase tests [10] , and careful observation of severe symptoms that need immediate attention [10]
pylori OipA has been shown to impact the Xc system, but its direct influence on the ferroptosis process of gastric mucosa cells remains unexplored, presenting a significant research gap that warrants further investigation
MariTides potential benefits include: Monthly dosing Significant weight loss Strong improvements in cardiometabolic markers A novel GIPR-blocking mechanism Extended half-life via antibody technology Early results showing improvements in blood sugar, HbA1c, and potentially blood pressure If approved, MariTide could offer a new option for millions living with obesity, type 2 diabetes, or related conditions like sleep apnea and cardiovascular disease
Qian, M
Head-to-Head Trial Shows Eli Lilly's Oral GLP-1 Orforglipron Outperforms Oral Semaglutide (ACHIEVE-3, The Lancet)
Engineered IL7/IL15 secreting iPSC-derived mesenchymal stromal cells reprogram the immunosuppressive tumor microenvironment and potentiate antitumor immunity